BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6970238)

  • 1. Platelet factor 4 levels in patients with coronary artery disease.
    White GL; Marouf AA
    J Lab Clin Med; 1981 Mar; 97(3):369-78. PubMed ID: 6970238
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet release in coronary heart disease: effect of antiplatelet drugs and coronary artery bypass graft.
    Al-Mondhiry H; Pierce WS; Pennock JL
    J Lab Clin Med; 1985 Mar; 105(3):397-402. PubMed ID: 2579177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of selected platelet functions and coronary disease risk factors in acute myocardial infarct].
    Florkiewicz H; Pluta A; Markiewicz M; Kowalewski J; Koziara Z; Dmoszyńska-Giannopoulou A; Szponar M
    Pol Tyg Lek; 1981 Oct; 36(41):1569-71. PubMed ID: 7335536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Platelet aggregation, circulating platelet aggregates and heparin-thrombin time in acute myocardial infarct].
    Florkiewicz H; Pluta A; Koziara Z; Markiewicz M; Kowalewski J; Dmoszyńska A; Szponar M
    Pol Tyg Lek; 1980 Dec; 35(48):1845-7. PubMed ID: 7208389
    [No Abstract]   [Full Text] [Related]  

  • 5. Platelet activation during exercise-induced myocardial ischemia.
    Green LH; Seroppian E; Handin RI
    N Engl J Med; 1980 Jan; 302(4):193-7. PubMed ID: 7350460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
    Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
    Artery; 1980; 8(1):73-9. PubMed ID: 6158934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of platelet factor IV for the evaluation of platelet function in patients with ischemic cardiopathy].
    de Teresa E; Lorenz MP; Vera A; Ortigosa J; Chamorro JL; de Artaza M
    Rev Esp Cardiol; 1981; 34(4):311-5. PubMed ID: 7323384
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection of soluble fibrin monomer complexes and of platelet factor 4 in the plasma of patients with diabetes mellitus].
    Smolenskij VS; Bokarev IN; Velikov VK; Savina TS; Frolova AI
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):879-84. PubMed ID: 94882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemistry, measurement, and clinical significance of platelet specific proteins.
    de Boer AC; Genton E; Turpie AG
    Crit Rev Clin Lab Sci; 1982; 18(2):183-211. PubMed ID: 6185275
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet factor 4 as a marker of platelet activation in patients with acute myocardial infarction.
    Dymicka-Piekarska V; Kemona H; Mantur M; Stogowski A; Kemona-Chetnik I; Bychowski J
    Rocz Akad Med Bialymst; 2000; 45():96-103. PubMed ID: 11712446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.
    Zotz RB; Klein M; Dauben HP; Moser C; Gams E; Scharf RE
    Thromb Haemost; 2000 Mar; 83(3):404-7. PubMed ID: 10744144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of release of platelet factor 4 during exercise-induced myocardial ischemia.
    Mathis PC; Wohl H; Wallach SR; Engler RL
    N Engl J Med; 1981 May; 304(21):1275-8. PubMed ID: 7219473
    [No Abstract]   [Full Text] [Related]  

  • 13. [Circulating blood platelet aggregates in various diseases].
    Donner L; Setková O; Tomásková K
    Vnitr Lek; 1983 Apr; 29(4):313-9. PubMed ID: 6868406
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma levels of platelet factor 4 in patients admitted to a coronary care unit.
    Kutti J; Safai-Kutti S; Svärdsudd K; Swedberg K; Wadenvik H
    Scand J Haematol; 1981 Mar; 26(3):235-40. PubMed ID: 7233087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [STA (serum thrombotic accelerator) activity, with special reference to changes in the STA activity in the serum from patients with hypercoagulable state. 2. Clinical studies].
    Nakamura Y
    Nihon Ketsueki Gakkai Zasshi; 1970 Apr; 33(2):256-72. PubMed ID: 5530049
    [No Abstract]   [Full Text] [Related]  

  • 16. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
    Moor E; Hamsten A; Blombäck M; Herzfeld I; Wiman B; Rydén L
    Thromb Haemost; 1994 Sep; 72(3):335-42. PubMed ID: 7531874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term effect of exercise on platelet factor 4 in normal subjects and in patients with coronary artery disease.
    Placanica G; Migliau G; Nasso G; Rosso R; Tallarico D; Migliau G
    Cardiologia; 1999 Nov; 44(11):993-6. PubMed ID: 10686775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of platelet activation products (platelet factor IV and beta-thromboglobulin) in a group of workers with long-term exposure to carbon disulfide].
    Craveri A; Lanfredini M; Tornaghi G; Frangione A; Milella AM; Ranieri R; Tonali M; Gatti L; Franco G; Moia M
    G Clin Med; 1980 Nov; 61(11):812-21. PubMed ID: 6165639
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasma malondialdehyde in patients with type 2 diabetes mellitus and in patients with coronary disease].
    Rábago-Velasco M; Cortez-Valero H; Aguilar-Parada E; Arellano-Pérez H; Vázquez-Chávez C; Jiménez-Villarruel M
    Gac Med Mex; 2000; 136(1):23-30. PubMed ID: 10721596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay.
    Handin RI; McDonough M; Lesch M
    J Lab Clin Med; 1978 Feb; 91(2):340-9. PubMed ID: 621432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.